Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Open Label, Dose-escalating, Multicenter Clinical Investigation to Evaluate the Safety and Effectiveness of THIODERM STRONG in the Correction of Nasolabial Folds.

NCT03650218 is registered in ClinicalTrials.gov with Croma-Pharma GmbH as lead sponsor.

NCT NCT03650218
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03650218 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Open Label, Dose-escalating, Multicenter Clinical Investigation to Evaluate the Safety and Effectiveness of THIODERM STRONG in the Correction of Nasolabial Folds.
Lead sponsor
Croma-Pharma GmbH
Phase
Not applicable
Overall status
Completed
Start date
July 10, 2018
Completion date
December 23, 2019
Enrollment
74 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

correction of nasolabial folds